Updated Prognostic Factors in Localized NSCLC

SIMPLE SUMMARY: In resected lung cancer, adjuvant and neoadjuvant chemotherapy following surgery are currently mainly based on TNM classification. With the validation and ongoing trials of targeted therapies in this situation, the relapse risk evaluation needs to be improved to better discriminate p...

Descripción completa

Detalles Bibliográficos
Autores principales: Garinet, Simon, Wang, Pascal, Mansuet-Lupo, Audrey, Fournel, Ludovic, Wislez, Marie, Blons, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945995/
https://www.ncbi.nlm.nih.gov/pubmed/35326552
http://dx.doi.org/10.3390/cancers14061400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945995/
https://www.ncbi.nlm.nih.gov/pubmed/35326552
http://dx.doi.org/10.3390/cancers14061400

Ejemplares similares